ロード中...
Effectiveness and Safety of Dimethyl Fumarate Treatment in Relapsing Multiple Sclerosis Patients: Real-World Evidence
INTRODUCTION: Dimethyl fumarate (DMF) has been recently approved as a disease-modifying therapy for the treatment of multiple sclerosis (MS). Post-marketing studies are important to confirm what was established in clinical trials. OBJECTIVE: To evaluate effectiveness and safety of DMF and to measure...
保存先:
| 出版年: | Neurol Ther |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer Healthcare
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5700902/ https://ncbi.nlm.nih.gov/pubmed/28780745 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40120-017-0080-x |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|